Lotrel (amlodipine besylate and benazepril hydrochloride)
10 mg/1 / 40 mg/1 · Capsule
By Novartis Pharmaceuticals Corporation
- NDC
- 0078-0379
- Route
- Oral
- Therapeutic class
- Angiotensin Converting Enzyme Inhibitor , Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker , Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker , Dihydropyridines [CS]
- Marketing category
- NDA
Package sizes
- 100 CAPSULE in 1 BOTTLE (0078-0379-05)NDC 0078-0379-05Available to order
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.
Related in Cardiovascular
See all →
Multivitamin with Fluoride
15 [iU]/1 / 60 mg/1 +9 · Tablet Chewable
Method Pharmaceuticals, LLC
Available to source
Multivitamin with Fluoride
15 [iU]/1 / 60 mg/1 +9 · Tablet Chewable
Method Pharmaceuticals, LLC
Available to source
Multivitamin with Fluoride
15 [iU]/1 / 60 mg/1 +9 · Tablet Chewable
Bryant Ranch Prepack
Available to source
Multivitamin with Fluoride
15 [iU]/1 / 60 mg/1 +9 · Tablet Chewable
Bryant Ranch Prepack
Available to source